Cannabis Law Report

SEPTEMBER 23, 2019

Marijuana and Cannabinoids: Health, Research and Regulatory Considerations (Position Paper). During the 20 th century, law enforcement and public policy activities have undermined opportunities for scientific exploration. Relevant AAFP Policy. Executive Summary. Marijuana Possession for Personal Use.

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40

The Cannigma

SEPTEMBER 12, 2021

THC is the most prevalent, famous and researched cannabinoid by far. The first researcher who identified and isolated THC, was the American Roger Adams (Shutterstock). However, the first researcher that identified and isolated THC was the American Roger Adams in the early 1940’s. Who discovered THC? Is THC safe?

THC 98

THC Research and Development Cannabinoids CBD 98

Cannabis Law Report

AUGUST 16, 2019

Immediately, regulators in other states with newly legalized programs will seek to avoid similar pitfalls while striking an effective regulatory balance: Oregon’s unlimited license policy is an opposite example of what other states yet prefer to avoid. Florida’s marijuana future is showing promise. In early August , J.

Marijuana 49

Marijuana Research and Development Seed-To-Sale Education 49

Cannabis Law Report

JULY 30, 2019

Beasley is forced by default to expand her knowledge base through scientific facts that warrant closer inspection and through accessible existing research, with few current cannabis case studies. Most reliable medical cannabis research filters into the U.S. org- A Brief History of Cannabis in the United States. . landscape. .

Marijuana 45

Marijuana Patients Research and Development Programs 45

Cannabis Law Report

AUGUST 6, 2021

Operating expenses : Total SG&A (“SG&A”) expenses in Q1 2022 declined by 17% versus Q1 2021, driven by year-over-year reductions in General & Administrative (“G&A”) and Research and Development (“R&D”) expenses partially offset by an increase in Sales & Marketing (“S&M”) expenses. hemp industry in the U.S.,

Vaping 105

Vaping Research and Development Data Business 105

The Cannigma

FEBRUARY 16, 2022

Listen & Subscribe: In light of Black History Month, we feel it is important and relevant to talk about how minorities in the United States and around the world have been disproportionately affected by drug policy and the war on drugs. EG: So, it is February, which means it’s Black History Month in the US right, Codi?

Trichome 73

Trichome Wellness and Beauty Cannabinoids Cannabis 73

SpeedWeed

DECEMBER 28, 2018

There’s nothing to justify the sky-high price (about $90 per day) beyond the cost of research and development to win FDA approval. But there’s nothing to justify the sky-high price (about $90 per day) beyond the cost of research and development to win FDA approval and Big Pharma’s insatiable thirst for profits.

Pharmaceutical 40

Pharmaceutical Research and Development Legalization CBD 40

Cannabis Law Report

SEPTEMBER 19, 2019

As far as we know, Senate Majority Leader Mitch McConnell still isn’t willing to make even the slightest move toward legal weed; however, there have been some wicked, unforeseen developments. . Doctors say they look forward to seeing more research on the subject as more states allow marijuana in smokable form.

Vaping 55

Vaping Hemp Education Patients 55

Cannabis Law Report

MAY 1, 2019

8 In January of this year, Attorney General Jeff Sessions rescinded an Obama-era policy which had de-prioritized federal prosecution of those involved in the cannabis industry in states which had legalized medical or recreational cannabis. any other Federal criminal statute.” 31 See Lisa N. 32 See , e.g., Retail Marijuana Rules, 1 Colo. . §

Legalization 45

Legalization Business Law Cannabis 45

Cannabis Law Report

NOVEMBER 2, 2021

This is a well researched and detailed report and is, we suggest required reading. As in this case, this also happened relatively early in the history of e-cigarettes, when the industry had much less oversight and there were undoubtedly many companies who cared more about cashing in than their customers.

THC 96

THC CBD Legalization Vaping 96

Cannabis Law Report

JUNE 1, 2021

Operating expenses : Total SG&A (“SG&A”) expenses in Q4 2021 declined by 25% versus Q4 2020, driven by year-over-year reductions in Sales & Marketing, and Research and Development (“R&D”) expenses. Drug Enforcement Administration (the “DEA”), the U.S. hemp industry in the U.S.,

Data 95

Data Vaping Supply Chain Business 95